week 2 tirzepatide 2: Not What I Expected π© No Appetite + Extreme Fatigue Best time to take tirzepatide
Description
GLP-1 medications affect individuals differently, and some athletes are more sensitive to slowed gastric emptying

In addition to the reduction in body weight, improvement in liver injury rates and resolution of steatohepatitis in 39% of cases, treatment with liraglutide was associated with lower progression of liver fibrosis compared to placebo

Lancet (Lond Engl) (2010) 375:144756
3.2 The mechanisms of GLP-1/GIP or GCG receptor dual agonists in MASLD 3.2.1 Metabolic regulatory effects Dual agonists targeting GLP-1 and GIP receptors have emerged as promising agents for metabolic regulation in MASLD

A provider who specializes in metabolic health and weight management understands how to optimize your treatment, when to adjust your dose, and how to address common challenges like appetite return or GI side effects
